[1
]From the Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School,
Boston (C.P.C.); AdventHealth Translational Research Institute, Orlando, FL (R.P.);
the University of Tennessee Health Science Center, Memphis (S.D.-J.); Pfizer, Groton,
CT (J.M., U.M., R.F., S.G.T.); Merck, Kenilworth, NJ (S.H., I.G.); the Department
of Endocrinology, University of Nantes, Nantes, France (B.C.); Rutgers School of Public
Health and Rutgers Cancer Institute of New Jersey, New Brunswick (W.J.S.); Pfizer...